Imatinib therapy in Hypereosinophilic Syndrome: a case of molecular remission

Leuk Res. 2005 Sep;29(9):1097-8. doi: 10.1016/j.leukres.2005.02.014.
No abstract available

Publication types

  • Case Reports
  • Comment
  • Letter

MeSH terms

  • Adult
  • Antineoplastic Agents / therapeutic use*
  • Benzamides
  • Humans
  • Hypereosinophilic Syndrome / drug therapy*
  • Imatinib Mesylate
  • Male
  • Middle Aged
  • Piperazines / therapeutic use*
  • Pyrimidines / therapeutic use*
  • Remission Induction*
  • Reverse Transcriptase Polymerase Chain Reaction

Substances

  • Antineoplastic Agents
  • Benzamides
  • Piperazines
  • Pyrimidines
  • Imatinib Mesylate